08:10-08:30
Advancing Global Collaboration in LDLT
All Forums
2025-10-17 Fri
Renji Hospital (UTC+8) 2025-10-17 Local Time
09:00-15:30 (UTC+8) 09:00-15:30 Local Time
Live Demonstration: Pediatric LDLT----Renji Hospital, Shanghai Jiao Tong University School of Medicine(Conference Room 619,6th Floor, Building 8)
Moderator：
Kang He
[China]
09:00-15:30
Pediatric LDLT：
5 BC (UTC+8) 2025-10-17 Local Time
15:30-17:00 (UTC+8) 15:30-17:00 Local Time
Council Meeting
15:30-16:30
Council Meeting-All iLDLTG Council Members：
2025-10-18 Sat
Grand-ballroom II (UTC+8) 2025-10-18 Local Time
08:00-08:10 (UTC+8) 08:00-08:10 Local Time
Opening Ceremony
08:00-08:10
Opening Ceremony and Welcome Address by Congress President and iLDLT President： Qiang Xia [China] Daxiang Wen [China]
08:10-08:50 (UTC+8) 08:10-08:50 Local Time
Plenary Session -Keynote lecture
08:30-08:50
Perspectives on Liver Transplantation: Innovation, Education, and Beyond
08:50-10:25 (UTC+8) 08:50-10:25 Local Time
Session 1(A) A Global Perspective of LDLT
10:20-10:25
Q&A (5 min)：
10:25-11:30 (UTC+8) 10:25-11:30 Local Time
Session 1(B) Technical Considerations in Minimally Invasive Donor Hepatectomy
10:55-11:10
How to establish a Robotic-assisted Donor Hepatectomy Program
11:25-11:30
Q&A (5 min)：
11:30-12:50 (UTC+8) 11:30-12:50 Local Time
Session 1(C) Transplant Oncology
12:00-12:15
Improving transplantibility for locally advanced HCC: the Hong Kong approach
12:30-12:35
Q&A (5 min)：
12:50-14:00 (UTC+8) 12:50-14:00 Local Time
Lunch
14:00-15:45 (UTC+8) 14:00-15:45 Local Time
Session 1(D) Technical Considerations in Recipient Surgery in LDLT
15:00-15:15
Complicated bile duct reconstruction in LDLT recipient
15:15-15:30
Liver transplantation for hepatocellular carcinoma: surgical technique and innovations
15:30-15:40
Q&A (10 min)：
15:40-15:45
Coffee Break：
15:45-17:45 (UTC+8) 15:45-17:45 Local Time
Session 1(E) ILLS/iLDLTG Expert Discussion on MIDH
15:45-16:05
Group 1: Position and Port sites： Alfred Kow Wei Chieh [Singapore] Chengpeng Zhong [China] Federica Cipriani [Italy] Mathieu D'Hondt [Belgium] Taizo Hibi [Japan] Worakitti Lapisatepun [Thailand]
16:05-16:25
Group 2: Hilum dissection: portal vein, hepatic artery： Mohamed Rela [India] Sreejith Sreekumar [India] Giammauro Berardi [Italy] Ruben Ciria [Spain] Thanh Le Van [Vietnam] Hugo Pinto Marques [Portugal] Rajesh Rajalingam [India] Taiga Wakabayashi [Japan]
16:25-16:45
16:45-17:05
17:05-17:25
Group 5: Vascular division and graft out： Brian Goh Kim Poh [Singapore] Mukesh Kumar [India] Fabrizio Di Francesco [Italy] Juan Pablo Rocca [USA] Marco Spada [Italy] Marco Vivarelli [Italy] Yao-Ming Wu [Taiwan, China]
17:25-17:45
Group 6: Anesthesia and Pain control： Justin Sangwook Ko [USA] Ryunga Kang [Republic of Korea] Dmitri Bezinover [USA] Michael D. Kaufman [USA] David Victor [USA] Jongman Kim [Republic of Korea]
Grand-ballroom III (UTC+8) 2025-10-18 Local Time
14:00-15:20 (UTC+8) 14:00-15:20 Local Time
Session 2(A) Transplant Pathology
14:00-14:15
Post-Liver Transplant Complications: Beyond Reiection and Recurrent Disease
14:15-14:30
Evolving Concepts in Liver Allograft Pathology: Insights from the Banff Liver Group
14:30-14:45
Liver allograft rejection in living donor liver transplant (LDLT) recipients
15:00-15:10
Q&A (10 min)：
15:10-15:20
Coffee break：
15:20-16:50 (UTC+8) 15:20-16:50 Local Time
Session 2(B) Dealing with Marginal Donors in LT
15:40-16:00
Long-term outcomes of LT recipients using Hepatitis virus-positive donor liver
16:00-16:20
From Assessment to Donation: Hepatologist’s Insights on Preparing Living Liver Donors
16:20-16:40
Strategies for expanding donor standards for split liver transplantation
16:40-16:50
Q&A (10 min)：
Pearl room (UTC+8) 2025-10-18 Local Time
09:00-10:20 (UTC+8) 09:00-10:20 Local Time
Session 3(A) Advanced Technology in LT
09:30-09:45
Advances in Imaging Techniques in Liver to Achieve Precision Liver Surgery
09:45-10:00
The prediction of hcc recurrence after liver transplantation based on radiomics
10:00-10:15
Integrated, intelligent and international hospital establishment for higher quality clinical medical care
10:15-10:20
Q&A (5 min)：
10:20-11:40 (UTC+8) 10:20-11:40 Local Time
Session 3(B) Xenotransplant
10:50-11:05
Clinical pig to human liver xenotransplantation: how far do we have to go?
11:05-11:20
Xenotransplantation: current status and a perspective on the future
11:35-11:40
Q&A (5 min)：
11:40-12:45 (UTC+8) 11:40-12:45 Local Time
Session 3(C) Expanding the Donor Pool in LT
11:40-11:55
Pros and Cons in Dual-graft Adult Living Donor Liver Transplantation
12:10-12:25
Waste-to-Resource Strategy in Liver Transplantation: Utilizing Discarded Partial Hepatectomy Grafts
12:25-12:40
Advancing Domino Liver Transplantation: Challenges, Strategies, and Future Perspectives
12:40-12:45
Q&A (5 min)：
12:45-13:15 (UTC+8) 12:45-13:15 Local Time
Luncheon Symposium
Moderator：
Zhijun Zhu
[China]
12:45-13:15
Optimizing immunosuppression: a path to consistency, innovation, and improved outcomes
13:15-13:45 (UTC+8) 13:15-13:45 Local Time
Luncheon Symposium
Moderator：
Jinzhen Cai
[China]
13:15-13:45
Tacrolimus in focus: Striking the optimal balance through data-driven care and personalization
14:00-15:30 (UTC+8) 14:00-15:30 Local Time
Session 3(D) Basic Science-Transplant Immunology
14:00-14:15
Liver transplantation – graft injury and cancer recurrence
14:15-14:30
Donor Quality, Preservation, and Short-Term Outcomes in Liver Transplant: A Single-Cell and Spatial Analysis of Ischemia-Reperfusion Injury
14:30-14:45
EBV-reactive KIR+ CX3CR1+ CD8+ T cells mediate liver transplantation tolerance by targeting alloreactive CD4+ T cells
14:45-15:00
The Dual Regulatory Roles of Macrophages in Acute Allogeneic Organ Graft Rejection
15:15-15:25
Q&A (10 min)：
15:30-18:04 (UTC+8) 15:30-18:04 Local Time
Session 3(E) Oral Abstract Session (Young Investigator Award 2025)
15:30-15:37
Graft inflow modulation in living donor liver transplantation
15:37-15:44
Impact of the High Baseline Anti-A/B Antibody titer on the clinical outcomes in ABO-incompatible Living Donor Liver Transplantation
15:44-15:51
SEVEN-DAY CREATININE: A CRYSTAL BALL FOR KIDNEY FATE AFTER LIVER TRANSPLANT
15:51-15:58
Perioperative Management, Ethical Concerns, and Outcomes of Pediatric Domino Liver Transplants from Maple Syrup Urine Disease Donors
15:58-16:05
Evaluation Of Thrombocytopenia and Platelet Transfusion in Liver Transplant Recipients at a Quaternary Care Centre in South India
16:05-16:12
Peri-operative risk factors and outcomes in acute-on-chronic liver-failure (ACLF) patients undergoing living donor liver transplantation (LT)
16:12-16:19
Is a Functional Liver Remnant Volume Below 30% an Absolute Contraindication for Laparoscopic Living Liver Donors?
16:19-16:26
The Infection Puzzle in Liver Transplantation: Risk Factors, Outcomes and Clinical Strategy
16:26-16:33
Living Donor Liver Transplantation for Unresectable Colorectal Liver Metastasis – The University of Rochester Experience
16:33-16:40
Transition from Laparoscopic to Robotic Donor Hepatectomy Transforms Right-Lobe Donor Practice—A Western Center Experience: Eliminates Hybrid Use/Conversions; Reduces Wound Morbidity
16:40-16:47
Antioxidant Therapy for Prevention of Ischemia-Reperfusion Injury in Living Donor Liver Transplantation
16:47-16:54
Does GRWR Really Matters when Graft Weight is More than 650 gms in Living donor Liver Transplantation ????
16:54-17:01
Global Outcomes of Open versus Laparoscopic versus Robotic Donor Hepatectomy: A Prospective Study from the International LDLT Registry (LDLTregistry.org)
17:01-17:08
Renal Recovery Benefit of Living Donor Compared to Deceased Donor Liver Transplantation in High-MELD(≥35) Recipients: A Propensity Score-Matched Study
17:08-17:15
Clinical heterogeneity of refractory ascites after pediatric liver transplantation modulates allograft rejection risk
17:15-17:22
Mapping the Immunometabolic Landscape: Dual Axes of CCL3-Driven Macrophage Polarization and Succinate Signaling Drive Fibrosis in Pediatric Liver Transplant Recipients
17:22-17:29
CRKP/MRSA Colonization Predicts Early Post-Liver Transplant Infection in Children: A Retrospective Matched Cohort Study
17:29-17:36
Circadian Timing of Liver Transplantation Influences the Rejection Related Injury: A Retrospective Cohort Study
17:36-17:43
Mechanism of liver circFADS2 inhibiting rejection after liver transplantation in children
17:43-17:50
Systematic Evaluation of Broad-PAM High-Fidelity Adenine Base Editors
17:50-17:57
In Vivo Base Editing Gene Therapy for Heterozygous Familial Hypercholesterolemia with GalNAc-modified Lipid Nanoparticles
Yangtze River Hall (UTC+8) 2025-10-18 Local Time
Digital Intelligence & HCC Healing Frontier – Hepatocellular Carcinoma & Liver Transplantation Summit
09:00-09:05 (UTC+8) 09:00-09:05 Local Time
Digital Intelligence & HCC Healing Frontier – Hepatocellular Carcinoma & Liver Transplantation Summit
Moderator：
Jianjun Zhang
[China]
09:00-09:05
Opening Remarks： Bo Li [China]
09:05-10:00 (UTC+8) 09:05-10:00 Local Time
Session 1 – Digital Intelligence & Innovation
09:25-09:45
Applications of AI in drug discovery and an emerging frontier in cancer research
09:45-10:00
Panel Discussion: Toward Precision Diagnosis and Treatment in HCC： Jinyang Gu [China] 录 陆 [China] Changxian li [China]
10:00-10:55 (UTC+8) 10:00-10:55 Local Time
Session 2 – Beyond the Horizon of HCC Healing
10:00-10:20
A New Paradigm of Conversion Therapy for HCC in the Immunotherapy Era
10:40-10:55
Panel Discussion: Integrated Strategies for Better Outcomes： Liuxin Cai [China] Zhidan Xu [China] Zhe Yang [China]
10:55-11:00 (UTC+8) 10:55-11:00 Local Time
Closing Remarks
Moderator：
Jianjun Zhang
[China]
10:55-11:00
Closing Remarks：
11:00-11:30 (UTC+8) 11:00-11:30 Local Time
Luncheon Symposium
Moderator：
Jinzhen Cai
[China]
11:00-11:30
Chinese guideline for clinical application of antithymocyte globulin in liver transplant recipients
11:30-11:50 (UTC+8) 11:30-11:50 Local Time
Luncheon Symposium
Forum on Liver Transplantation and Liver Cancer
12:00-12:10 (UTC+8) 12:00-12:10 Local Time
Forum on Liver Transplantation and Liver Cancer
12:00-12:15
Opening：
12:10-13:25 (UTC+8) 12:10-13:25 Local Time
Section 1 Discussion on Key Technologies of Liver Transplantation
12:10-12:25
Management of Complex Portal Vein Thrombosis During Liver Transplantation
12:40-12:55
Creation and Application of New Techniques for Simultaneous Liver-Kidney Transplantation (SLKT)
12:55-13:10
13:10-13:25
Endo Lab：
13:25-14:25 (UTC+8) 13:25-14:25 Local Time
Section 2 Standardized Multidisciplinary Construction of Liver Cancer
13:40-13:55
Sharing the construction experience of the AI empowered liver cancer center
13:55-14:10
Discussion： Bo Wang [China] Shengdong Wu [China] Yihe Yan [China]
14:25-14:30 (UTC+8) 14:25-14:30 Local Time
Closing Remarks
14:25-14:30
Closing Remarks：
Pre-OCOT Symposium -Zhi Shu Zhong Hua
15:00-16:20 (UTC+8) 15:00-16:20 Local Time
Session 1
15:00-15:10
Opening Speech： Jianjun Zhang [China]
15:30-15:50
Clinical management of renal dysfunction in liver transplantation and immunosuppressive agents
15:50-16:10
16:20-17:30 (UTC+8) 16:20-17:30 Local Time
Session 2
16:20-16:40
Long-term follow-up management strategy after renal transplantation
16:40-17:00
Exploration of basiliximab in the treatment of acute TCMR in renal transplant
17:00-17:20
Panel discussion： Shaojun Ye [China] Lan Zhu [China] Jina Wang [China] xiaodong yuan [China] Yan Qin [China]
17:20-17:40
Closing： ruiming rong [China]
2025-10-19 Sun
Grand-ballroom II (UTC+8) 2025-10-19 Local Time
08:30-09:40 (UTC+8) 08:30-09:40 Local Time
Session 1 (F) Graft Matching in LDLT
09:30-09:40
Q&A (10 min)：
09:40-10:50 (UTC+8) 09:40-10:50 Local Time
Session 1(G) Paediatric LT -- Key Issues to consider
10:10-10:25
Indication of liver transplantation for metabolic liver disease in pediatric patients
10:25-10:40
Auxiliary Liver Transplantation for the Treatment of Acute Liver Failure in Children
10:40-10:50
Q&A (10 min)：
10:50-11:30 (UTC+8) 10:50-11:30 Local Time
iLDLTG GENERAL ASSEMBLY
12:00-12:25 (UTC+8) 12:00-12:25 Local Time
Luncheon Symposium
Moderator：
Jianjun Zhang
[China]
12:00-12:20
Evaluation of the clinical value of drug-eluting bead transarterial chemoembolization (DEB-TACE) in primary liver cancer
12:20-12:25
Discussion： Weihua Song [China]
12:25-13:00 (UTC+8) 12:25-13:00 Local Time
Luncheon Symposium
12:25-12:40
Subsegment-based ICG fluorescence-guided laparoscopic anatomic hepatectomy
12:40-12:55
Comprehensive Management of Bleeding Prevention in Liver Transplantation
12:55-13:00
Discussion： Yu Zhang [China] Lin Wei [China]
13:00-14:20 (UTC+8) 13:00-14:20 Local Time
Session 1(H) Vanguard Project Presentation（10 min. presentations with 5 minutes Q&A）
Moderator：
Yuji Soejima
[Japan]
13:00-13:05
Introduction of Vanguard Multicenter committee and ongoing projects
14:25-16:25 (UTC+8) 14:25-16:25 Local Time
Session 1(I) Video demonstration
Moderator：
Kang He
[China]
14:25-14:55
Stepwise Institutional Progression to Total Robotic Liver Transplantation Using Both Deceased and Living Donor Grafts
15:25-15:55
How to lmplant Modified Right Lobe Graft having V5,V8, and Inferior Right
16:25-16:30 (UTC+8) 16:25-16:30 Local Time
Closing Remarks
Grand-ballroom III (UTC+8) 2025-10-19 Local Time
08:30-09:40 (UTC+8) 08:30-09:40 Local Time
Session 2(C) Immunological Considerations in Liver Transplantation
09:00-09:15
Donor-derived Regulatory DC infusion in Immune Tolerance: what we know
09:30-09:45
Q&A (10 min)：
09:40-10:50 (UTC+8) 09:40-10:50 Local Time
Session 2(D) Advances in Machine Perfusion in LT
10:10-10:25
The current status and future of ischemic-free organ transplantation
10:40-10:50
Q&A (10 min)：
11:30-13:00 (UTC+8) 11:30-13:00 Local Time
Luncheon Symposium
11:30-12:00
Perioperative cholestatic liver disease: early recognition and clinical response
11:30-12:00
13:00-14:25 (UTC+8) 13:00-14:25 Local Time
Session 2(E) Peri-operative Considerations in Liver Transplantation
13:15-13:30
Clinical Management of Perioperative Infections in Liver Transplantation
13:30-13:45
What is the timing of CBP after liver transplantation in critical liver failure recipients？
13:45-14:00
Management of antibody mediated rejection after liver transplantation
14:00-14:15
Diagnosis, Treatment, and Research of Severe Peri-operative Infections in Liver Transplantation
14:15-14:30
Q&A (10 min)：
14:25-15:55 (UTC+8) 14:25-15:55 Local Time
Session 2(F) Cell & Gene therapy -- From Bench to Bedside
14:25-14:45
From Lab to Clinic: Translating Bioengineered Liver Organoids for Precision Modeling and Regeneration
14:45-15:05
Progenitor Hepatocytes in Liver Disease: Therapeutic Potential and Translational Advances
15:45-15:55
Q&A (10 min)：
Pearl room (UTC+8) 2025-10-19 Local Time
Kidney Transplant
08:00-09:00 (UTC+8) 08:00-09:00 Local Time
Section 1
08:15-08:30
Practice and exploration in managing recurrent kidney disease after transplantation
08:45-09:00
09:00-10:15 (UTC+8) 09:00-10:15 Local Time
Section 2
Moderator：
Ye Tian
[China]
丨
Hua Zhou
[China]
丨
Longkai Peng
[China]
丨
Ming Zhao
[China]
丨
Honglan Zhou
[China]
09:15-09:30
Establishment of kidney organoid platforms and prospects for large-scale application
09:30-09:45
Molecular Pathology Empowers Kidney Transplantation Diagnosis and Treatment: A Leap from Mechanism Elucidation to Precision Prognosis and Its Future
09:45-10:00
10:00-10:15
Coffee break：
10:15-11:15 (UTC+8) 10:15-11:15 Local Time
Section 3
10:30-10:45
Advances in antibody research and application in kidney transplantation
10:45-11:00
Differentiation after Syndrome Differentiation: De Novo Malignancies After Transplantation
11:00-11:15
11:15-12:30 (UTC+8) 11:15-12:30 Local Time
Session 4
11:15-11:30
2025 ATC: International Hot Topics and New Advances in ABMR Prevention and Treatment in Kidney Transplantation
11:30-11:45
Multitarget therapy for antibody-mediated rejection after kidney transplantation
11:45-12:00
Clinical effects and mechanism exploration of CD38 monoclonal antibody combined with ACTH in improving proteinuria after recurrent FSGS in transplanted kidney
12:15-12:30
12:30-14:00 (UTC+8) 12:30-14:00 Local Time
Luncheon Symposium
Moderator：
ruiming rong
[China]
12:30-13:00
Advances in clinical application of mTOR inhibitors in organ transplantation
Organ Donation and Management
14:10-15:25 (UTC+8) 14:10-15:25 Local Time
Session 1
14:55-15:10
Technological Innovation, Institutional Reconstruction and Governance of Global Donation and Transplantation from Multiple Perspectives
15:10-15:25
15:25-16:50 (UTC+8) 15:25-16:50 Local Time
Session 2
15:55-16:10
How to Do a Good Job in Organ Donation from the Perspective of the Intensive Care Unit
16:25-16:40
16:50-18:05 (UTC+8) 16:50-18:05 Local Time
Session 3
17:50-18:05
Yangtze River Hall (UTC+8) 2025-10-19 Local Time
Heart/Lung/Pancreas/Intestine Transplant
08:00-09:30 (UTC+8) 08:00-09:30 Local Time
One. Islet and Regenerative Islet Transplantation
Moderator：
Linong Ji
[China]
丨
Xiaoying Li
[China]
丨
Tao Yang
[China]
丨
Yan Bi
[China]
丨
Yongquan Shi
[China]
08:00-08:30
“Beyond Immunosuppression: Next-Generation Cell Therapies for T1DM（40 years anniversary of the invention of the Ricordi Chamber and Automated method）”
09:30-09:45
09:45-10:05 (UTC+8) 09:45-10:05 Local Time
Two. Heart, Lung, Pancreas, and Small Intestine Transplantation
10:05-10:25
Technical Optimization of Lung Transplantation for Pulmonary Fibrosis
10:25-10:45
Exploration and Considerations of Arterial and Venous Shunting Techniques in Donor Pancreas and Spleen
11:05-11:25
11:25-13:00 (UTC+8) 11:25-13:00 Local Time
Three. Islet Transplantation + Regenerative/Xenogeneic Islets
12:25-12:45
Research and Development of Candidate Drugs Targeting ACLY for Hyperlipidemia and Metabolic-Associated Fatty Liver Disease
12:45-13:05
Nursing in Transplant
14:00-14:10 (UTC+8) 14:00-14:10 Local Time
Theme: Focus · Empower · Integrate — Building a New Model of High-Quality Transplant Nursing
14:00-14:05
Address： Huiqin Xi [China]
14:05-14:10
Group photo：
14:10-15:50 (UTC+8) 14:10-15:50 Local Time
Exploring Cutting-Edge Nursing Models, Empowering the Development of Transplant Nursing
14:10-14:30
Development and Prospects of the Nursing Discipline at Shanghai Jiao Tong University School of Nursing
14:30-14:50
Organ Donation and Allocation: Defending the Family-First Principle in China"
14:50-15:10
Evidence-Based Clinical Practice of Exercise Rehabilitation for Kidney Transplant Recipients
15:30-15:50
Discussant：
15:40-15:50
Coffee break：
15:50-17:20 (UTC+8) 15:50-17:20 Local Time
Enhancing Professional Competence and Quality Control, Leading the Development of Specialized Transplant Nursing
15:50-16:10
Development and Practice of the Core Competency Training System for Transplant Specialist Nurses
16:10-16:30
Postoperative Rehabilitation Management of Critically Ill Transplant Patients
16:50-17:10
Experience Sharing from Transplant Specialist Nurses in Singapore
17:10-17:20
Discussant：